Key result
Metabolic syndrome and diabetes mellitus were associated with significant coronary artery calcification (43% and 64% vs 24% for neither) and improved risk prediction over FRS alone (P<.0001).
Why the study?
Are metabolic syndrome and diabetes mellitus associated with significant coronary artery calcification compared to patients with neither condition?
Cross-Sectional (n=356)
Are metabolic syndrome and diabetes mellitus associated with significant coronary artery calcification compared to patients with neither condition?
Absolute Event Rate: 43% vs 24%
p-value: p=<.0001
Metabolic syndrome and diabetes mellitus are associated with an increased risk of subclinical atherosclerosis and provide incremental predictive value for significant coronary artery calcification over the Framingham risk score alone.
May aid CAC risk stratification beyond FRS in metabolic syndrome or diabetes; leaves open prospective outcome validation.
The authors compared the metabolic syndrome status and Framingham 10-year coronary heart disease risk score (FRS) with the coronary artery calcification (CAC) in subclinical atherosclerosis. In all, 356 consecutive patients who underwent coronary artery calcium scanning were studied. Participants' metabolic syndrome status (by National Cholesterol Education Program Adult Treatment Panel III [NCEP ATP III] guidelines) and FRS were measured. The association between the metabolic syndrome, diabetes mellitus (DM), FRS, and CAC was analyzed by multivariable logistic regression analyses. These analyses were adjusted for demographics, age, sex, and conventional cardiovascular risk factors. The prevalence of significant CAC (CAC score >/=100) in those with DM, the metabolic syndrome, and neither condition was 64%, 43%, and 24%, respectively. The receiver operating characteristic C statistic for the prediction of significant CAC by the NCEP ATP III criteria for FRS, the metabolic syndrome, and DM was 0.61, 0.67, and 0.72, respectively, and increased significantly to 0.78 and 0.90 respectively for the metabolic syndrome and DM when added to the prediction models (P<.0001). This study suggests that the metabolic syndrome and DM are associated with increased risk of subclinical atherosclerosis. In addition, the presence of the metabolic syndrome or DM with increased FRS has incremental value over the FRS, DM, or the metabolic syndrome alone in predicting significant CAC.
No takes yet. Share an insight, caveat, or question.
Ibebuogu et al. (2009) conducted a cross-sectional in Subclinical atherosclerosis (n=356). Metabolic syndrome and diabetes mellitus vs. Neither condition was evaluated on Significant coronary artery calcification (CAC score ≥100) (p=<.0001). Metabolic syndrome and diabetes mellitus were associated with significant coronary artery calcification (43% and 64% vs 24% for neither) and improved risk prediction over FRS alone (P<.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: